Physician profile
Fletcher C Derrick, JR.
NPI 1851345227
$385.91
in general payments reported to CMS, 2019-2025
12 companies · $79.80 in 2025
The $79.80 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2025: $79.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $81.07 | 2019 | |
| Janssen Biotech, INC. | $50.15 | 2019 | |
| Abbvie INC. | $48.49 | 2025 | |
| Coloplast Corp | $43.56 | 2019 | |
| Endo Pharmaceuticals INC. | $31.61 | 2019 | |
| Abbott Laboratories | $31.31 | 2025 | Freestyle Libre 3 |
| Blue Earth Diagnostics | $22.53 | 2019 | |
| Amgen INC. | $18.22 | 2019 | |
| Rgh Enterprises LLC | $17.01 | 2019 | |
| Smith+Nephew, INC. | $14.78 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $13.94 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fletcher Derrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.